Table 2 Clinical outcomes according to the soluble neprilysin level
Outcome | Neprilysin | Log rank, P value | |
|---|---|---|---|
≤76.0 pg/ml (n = 348) | > 76.0 pg/ml (n = 346) | ||
All-cause death | 20 (5.7%) | 28 (8.1%) | 0.213 |
Cardiovascular death | 10 (2.9%) | 15 (4.3%) | 0.292 |
Nonfatal myocardial infarction | 0 (0%) | 1 (0.3%) | 0.316 |
Nonfatal stroke | 2 (0.6%) | 4 (1.2%) | 0.408 |
Revascularization | 5 (1.4%) | 5 (1.4%) | 0.968 |
Hospitalization for heart failure | 3 (0.9%) | 2 (0.6%) | 0.664 |
Major adverse cardiovascular events | 19 (5.5%) | 24 (6.9%) | 0.382 |